Network pharmacology revealed 36 diabetes-related targets, with nine core targets (PPARA, FXR, PTGS2, FABP1, HMGCR, ESRRA, CYP19A1, NR3C1, G6PD) implicated in nuclear receptor signaling, lipid metabolism, and inflammatory pathways. This evidence concerns the gene FABP1 and diabetes mellitus.